Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Aminophenazone

Related Products

Hot Products

Name

Aminophenazone

EINECS 200-365-8
CAS No. 58-15-1 Density 1.17 g/cm3
PSA 30.17000 LogP 1.55040
Solubility soluble in water Melting Point 107-109 °C(lit.)
Formula C13H17N3O Boiling Point 319.7 °C at 760 mmHg
Molecular Weight 231.297 Flash Point 125.9 °C
Transport Information UN 2811 6.1/PG 3 Appearance white crystalline powder
Safety 26-36-36/37/39 Risk Codes 36/37/38-21/22
Molecular Structure Molecular Structure of 58-15-1 (Aminophenazone) Hazard Symbols HarmfulXn
Synonyms

1,5-Dimethyl-4-dimethylamino-2-phenyl-3-pyrazolone;1-Phenyl-2,3-dimethyl-4-dimethylaminopyrazol-5-one;3-Keto-1,5-dimethyl-4-dimethylamino-2-phenyl-2,3-;4-(Dimethylamino)antipyrine;Dimethylamino-analgesine;

Article Data 44

Aminophenazone Specification

The Aminopyrine, with the CAS registry number 58-15-1 and EINECS registry number 200-365-8, has the systemaic name of 4-(dimethylamino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one. And the molecular formula of this chemical is C13H17N3O. It is an air & light sensitive chemical, and belongs to the product category of Miscellaneous.

The physical properties of Aminopyrine are as following: (1)ACD/LogP: 0.76; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 0.71; (4)ACD/LogD (pH 7.4): 0.76; (5)ACD/BCF (pH 5.5): 1.99; (6)ACD/BCF (pH 7.4): 2.22; (7)ACD/KOC (pH 5.5): 55.23; (8)ACD/KOC (pH 7.4): 61.51; (9)#H bond acceptors: 4; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 26.79 Å2; (13)Index of Refraction: 1.614; (14)Molar Refractivity: 68.33 cm3; (15)Molar Volume: 196 cm3; (16)Polarizability: 27.08×10-24cm3; (17)Surface Tension: 49 dyne/cm; (18)Density: 1.17 g/cm3; (19)Flash Point: 125.9 °C; (20)Enthalpy of Vaporization: 56.13 kJ/mol; (21)Boiling Point: 319.7 °C at 760 mmHg; (22)Vapour Pressure: 0.000333 mmHg at 25°C.

Preparation of Aminopyrine: By the catalytic hydrogenation of Ampyrone, Aminopyrine crude product is obtained. Heat the crude product, ethanol and active carbon to a certain temperature, and the product is obtained after a series of decolourization, pressure filtration, cooling crystallization, washing and dryness.

Uses of Aminopyrine: With analgesic, anti-inflammatory, and antipyretic properties, it is used in medicine. What's more, a breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of cytochrome P-450 metabolic activity in liver function tests. It can be used as analytical reagent.

You should be cautious while dealing with this chemical. It irritates eyes, respiratory system and skin, and it is also harmful if swalled. Therefore, you had better take the following instructions: Wear suitable protective clothing, and in case of contacting with eyes, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C2\C(=C(/N(N2c1ccccc1)C)C)N(C)C
(2)InChI: InChI=1/C13H17N3O/c1-10-12(14(2)3)13(17)16(15(10)4)11-8-6-5-7-9-11/h5-9H,1-4H3
(3)InChIKey: RMMXTBMQSGEXHJ-UHFFFAOYAM

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LDLo intravenous 100mg/kg (100mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: NAUSEA OR VOMITING
Journal of Pharmacology and Experimental Therapeutics. Vol. 39, Pg. 177, 1930.
cat LDLo oral 100mg/kg (100mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 73, Pg. 312, 1941.
dog LD50 intravenous 121mg/kg (121mg/kg) BEHAVIORAL: ANALGESIA Archives Internationales de Pharmacodynamie et de Therapie. Vol. 149, Pg. 571, 1964.
dog LD50 oral 220mg/kg (220mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 719, 1971.
frog LDLo parenteral 900mg/kg (900mg/kg) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 166, Pg. 437, 1932.
guinea pig LD50 intravenous 130mg/kg (130mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 88, Pg. 142, 1951.
guinea pig LD50 oral 910mg/kg (910mg/kg)   Schweizerische Medizinische Wochenschrift. Vol. 84, Pg. 351, 1954.
guinea pig LDLo subcutaneous 250mg/kg (250mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 213, 1955.
hamster LD50 intraperitoneal 380mg/kg (380mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1024, 1970.
mammal (species unspecified) LD50 intraperitoneal 300mg/kg (300mg/kg)   Farmatsevtichnii Zhurnal Vol. 29(2), Pg. 25, 1974.
man LDLo unreported 220mg/kg (220mg/kg)   "Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970Vol. 2, Pg. 73, 1970.
mouse LC50 inhalation 20410mg/m3 (20410mg/m3)   Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 34(10), Pg. 36, 1969.
mouse LD50 intramuscular 306mg/kg (306mg/kg) BEHAVIORAL: ANALGESIA Oyo Yakuri. Pharmacometrics. Vol. 13, Pg. 109, 1977.
mouse LD50 intraperitoneal 169mg/kg (169mg/kg)   Russian Pharmacology and Toxicology Vol. 35, Pg. 293, 1972.
mouse LD50 intravenous 78mg/kg (78mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ATAXIA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Oyo Yakuri. Pharmacometrics. Vol. 16, Pg. 1011, 1978.
mouse LD50 oral 300mg/kg (300mg/kg)   Pharmaceutical Chemistry Journal Vol. 30, Pg. 374, 1996.
mouse LD50 subcutaneous 248mg/kg (248mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 8, Pg. 494, 1977.
mouse LD50 unreported 300mg/kg (300mg/kg)   Farmakologiya i Toksikologiya Vol. 39, Pg. 148, 1976.
rabbit LD50 intravenous 80mg/kg (80mg/kg)   Bollettino Chimico Farmaceutico. Vol. 102, Pg. 602, 1963.
rabbit LD50 oral 600mg/kg (600mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ATAXIA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Oyo Yakuri. Pharmacometrics. Vol. 16, Pg. 1011, 1978.
rabbit LDLo subcutaneous 250mg/kg (250mg/kg)   "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935.
rat LD50 intramuscular 340mg/kg (340mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 10, Pg. 665, 1960.
rat LD50 intraperitoneal 190mg/kg (190mg/kg)   Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 68, Pg. 442, 1972.
rat LD50 intravenous 98mg/kg (98mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ATAXIA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Oyo Yakuri. Pharmacometrics. Vol. 16, Pg. 1011, 1978.
rat LD50 oral 285mg/kg (285mg/kg)   Russian Pharmacology and Toxicology Vol. 51, Pg. 183, 1988.
rat LD50 rectal 310mg/kg (310mg/kg)   Pharmazie. Vol. 18, Pg. 807, 1963.
rat LD50 subcutaneous 295mg/kg (295mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 229, 1958.
rat LD50 unreported 176mg/kg (176mg/kg)   Farmakologiya i Toksikologiya Vol. 39, Pg. 14, 1976.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 58-15-1